Fu J, Wang R, He J, Liu X, Wang X, Yao J
Front Immunol. 2025; 16:1508023.
PMID: 40028337
PMC: 11867950.
DOI: 10.3389/fimmu.2025.1508023.
Huang S, Lu Y, Fang W, Huang Y, Li Q, Xu Z
Open Life Sci. 2025; 20(1):20221051.
PMID: 40026360
PMC: 11868719.
DOI: 10.1515/biol-2022-1051.
Dang W, Hao T, Li N, Zhang H, Li Z, Yu H
Front Aging. 2025; 6:1488528.
PMID: 39975850
PMC: 11837265.
DOI: 10.3389/fragi.2025.1488528.
Alaei M, Koushki K, Taebi K, Yousefi Taba M, Keshavarz Hedayati S, Shahbaz S
RSC Adv. 2025; 15(7):5426-5451.
PMID: 39967886
PMC: 11833603.
DOI: 10.1039/d4ra07798a.
Lee E, Chang Y
Cells. 2025; 14(3).
PMID: 39936960
PMC: 11817173.
DOI: 10.3390/cells14030168.
Integrating epigenetic modification and stem cell therapy strategies: A novel approach for advancing Alzheimer's disease treatment - A literature review.
Widaja E, Pawitan J
Narra J. 2025; 4(3):e935.
PMID: 39816083
PMC: 11731673.
DOI: 10.52225/narra.v4i3.202.
Advancing Alzheimer's Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies.
Mohd Murshid N, Mohd Sahardi N, Makpol S
Int J Mol Sci. 2025; 26(1.
PMID: 39796097
PMC: 11719782.
DOI: 10.3390/ijms26010241.
Anthranilic Acid-G-Protein Coupled Receptor109A-Cytosolic Phospholipase A2-Myelin-Cognition Cascade: A New Target for the Treatment/Prevention of Cognitive Impairment in Schizophrenia, Dementia, and Aging.
Oxenkrug G
Int J Mol Sci. 2025; 25(24.
PMID: 39769034
PMC: 11675959.
DOI: 10.3390/ijms252413269.
Long-Term Treatment with Fluoroethylnormemantine (FENM) Alleviated Memory Deficits, Amyloid Pathology, and Microglial Reaction in APP/PS1 Mice.
Freyssin A, Carles A, Moha B, Rubinstenn G, Maurice T
ACS Pharmacol Transl Sci. 2024; 7(12):4069-4082.
PMID: 39698294
PMC: 11650732.
DOI: 10.1021/acsptsci.4c00522.
Lycium barbarum Extract Enhanced Neuroplasticity and Functional Recovery in 5xFAD Mice via Modulating Microglial Status of the Central Nervous System.
Sun Z, Liu J, Chen Z, So K, Hu Y, Chiu K
CNS Neurosci Ther. 2024; 30(11):e70123.
PMID: 39564756
PMC: 11576918.
DOI: 10.1111/cns.70123.
Exploring the anti-inflammatory effects of curcumin encapsulated within ferritin nanocages: a comprehensive in vivo and in vitro study in Alzheimer's disease.
Morasso C, Truffi M, Tinelli V, Stivaktakis P, Di Gerlando R, Francesca D
J Nanobiotechnology. 2024; 22(1):718.
PMID: 39551771
PMC: 11571668.
DOI: 10.1186/s12951-024-02897-4.
Network dynamics-based subtyping of Alzheimer's disease with microglial genetic risk factors.
Choi J, Lee J, Kang U, Chang H, Cho K
Alzheimers Res Ther. 2024; 16(1):229.
PMID: 39415193
PMC: 11481771.
DOI: 10.1186/s13195-024-01583-9.
Microglia in Neurodegenerative Diseases.
Awogbindin I, Wanklin M, Verkhratsky A, Tremblay M
Adv Neurobiol. 2024; 37:497-512.
PMID: 39207709
DOI: 10.1007/978-3-031-55529-9_27.
Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches.
Yassaghi Y, Nazerian Y, Ghasemi M, Nazerian A, Sayehmiri F, Perry G
J Cell Mol Med. 2024; 28(15):e18554.
PMID: 39103747
PMC: 11300171.
DOI: 10.1111/jcmm.18554.
Effect of Trehalose Disaccharide on Activation of Microglia and Indices of Systemic Inflammation in an Experimental Model of Alzheimer's Disease.
Zozulya S, Akopyan A, Tenditnik M, Ovsyukova M, Korolenko T, Klyushnik T
Bull Exp Biol Med. 2024; 177(2):207-211.
PMID: 39090471
DOI: 10.1007/s10517-024-06157-1.
The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets.
AmeliMojarad M, AmeliMojarad M
CNS Neurosci Ther. 2024; 30(7):e14856.
PMID: 39031970
PMC: 11259573.
DOI: 10.1111/cns.14856.
The emerging role of brain neuroinflammatory responses in Alzheimer's disease.
AmeliMojarad M, AmeliMojarad M, Cui X
Front Aging Neurosci. 2024; 16:1391517.
PMID: 39021707
PMC: 11253199.
DOI: 10.3389/fnagi.2024.1391517.
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer's disease: a longitudinal study.
Nabizadeh F, Seyedmirzaei H, Karami S
Sci Rep. 2024; 14(1):15318.
PMID: 38961148
PMC: 11222555.
DOI: 10.1038/s41598-024-66211-w.
Supervised latent factor modeling isolates cell-type-specific transcriptomic modules that underlie Alzheimer's disease progression.
Hodgson L, Li Y, Iturria-Medina Y, Stratton J, Wolf G, Krishnaswamy S
Commun Biol. 2024; 7(1):591.
PMID: 38760483
PMC: 11101463.
DOI: 10.1038/s42003-024-06273-8.
The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets.
Adamu A, Li S, Gao F, Xue G
Front Aging Neurosci. 2024; 16:1347987.
PMID: 38681666
PMC: 11045904.
DOI: 10.3389/fnagi.2024.1347987.